A novel and de novo deletion in the OCRL1 gene associated with a severe form of Lowe syndrome

Int Urol Nephrol. 2013 Dec;45(6):1767-71. doi: 10.1007/s11255-012-0246-5. Epub 2012 Jul 21.

Abstract

The oculocerebrorenal syndrome of Lowe (OCRL) is an X-linked disorder. The mutation of the gene OCRL1 localized at Xq26.1, coding for the enzyme phosphatidylinositol (4,5) bisphosphate (PIP2P) 5-phosphatase, is responsible for the phenotypic characteristics of the disease. We report a 22-year-old male with a severe form of OCRL syndrome, diagnosed on the basis of congenital cataracts, severe psychomotor and cognitive deficits, and renal tubular dysfunction without Fanconi syndrome. The patient presented low molecular weight proteinuria, nephrocalcinosis, nephrolithiasis, rickets, and growth retardation and developed progressive renal failure. Genetic analysis showed a novel and de novo deletion of exons 10-13 in the OCRL1 gene.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Exons
  • Humans
  • Male
  • Oculocerebrorenal Syndrome / genetics*
  • Phosphoric Monoester Hydrolases / genetics*
  • Sequence Deletion*
  • Severity of Illness Index
  • Young Adult

Substances

  • Phosphoric Monoester Hydrolases
  • OCRL protein, human